Sygnature Chemical Services has been selected by the University of Leicester to support a Wellcome Trust Seeding Drug Discovery Initiative (SDDI) funded research programme.
Under the terms of the agreement, Sygnature will provide synthetic, medicinal and computational chemistry services to help the university identify new treatments for the serious neurological handicaps associated with invasive pneumococcal diseases.
